Technical corrections only. The two versions of the bill are substantively identical, with v4 adding a clerk's name to the attestation and including Senate procedural information. No substantive policy changes were made between v3 and v4.
Women and Lung Cancer Research and Preventive Services Act of 2025
- Sponsor
- Rep. Boyle, Brendan F. [D-PA-2]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Apr 22, 2026
Bottom line
This bill mandates a comprehensive interagency review to identify gaps and opportunities in lung cancer research, prevention, and awareness specifically for women and underserved populations.
What it actually does
This bill directs the Secretary of Health and Human Services, in consultation with the Secretaries of Defense and Veterans Affairs, to conduct an interagency review. This review will evaluate the status of research on lung cancer in women and underserved populations, assess access to preventive services, and identify opportunities for strategic public awareness and education campaigns. A report detailing the findings and recommendations must be submitted to Congress within two years of the bill's enactment.
Proponents argue
Supporters argue that this bill addresses critical disparities in lung cancer outcomes by focusing federal research and prevention efforts on vulnerable groups. They contend that a dedicated, coordinated review will lead to a better understanding of unique risk factors, improved early detection strategies, and more effective public health interventions, ultimately enhancing health equity and saving lives.
Opponents contend
Critics might argue that while the bill's goals are laudable, federal agencies already have ongoing initiatives to address health disparities and cancer research. They may contend that a new mandated review could duplicate existing efforts, divert resources from direct patient care or ongoing research projects, or create an unfunded administrative burden without necessarily yielding significant new insights.
The bill is very short and easy to read, allowing ample time for evaluation of its provisions.
Section 2(a) and 2(b)
Interagency Review on Lung Cancer in Women and Underserved Populations
This provision mandates the Secretary of Health and Human Services, in collaboration with the Secretaries of Defense and Veterans Affairs, to conduct a thorough interagency review. The review will assess the current state of research on lung cancer in women and underserved populations, evaluate access to lung cancer preventive services, and identify opportunities for strategic public awareness and education campaigns. It specifically requires the review to cover previous research outcomes, existing activities, knowledge gaps, and opportunities for collaborative, innovative research, including environmental and genomic factors, and advances in imaging technology. Furthermore, it calls for developing a national lung cancer screening strategy and a national public education campaign.
Supporters argue
Supporters argue that a dedicated interagency review is crucial to identify and address specific gaps in lung cancer research and care for women and underserved populations, who may face unique risk factors or barriers to screening and treatment. This coordinated effort will ensure a comprehensive approach to improving public health outcomes.
Critics contend
Critics might contend that federal agencies already have ongoing initiatives to address health disparities and cancer research, and a new mandated review could duplicate efforts or divert resources from direct patient care or existing research projects without adding significant new insights. They may also question the necessity of a new mandate for activities that could be undertaken through existing administrative channels.
Tradeoffs
The bill balances the critical need for focused attention on specific vulnerable populations with the potential for administrative overhead and resource allocation within existing agency budgets. It aims to improve health equity but requires agencies to prioritize this review among other ongoing public health efforts, potentially shifting resources.